2976-856x

NAR Molecular Medicine

Oxford University Press

View prefix report (10.1093)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Deposit reference lists for 9 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact9 DOIs
2

Attach ORCID iDs across 7 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact7 DOIs
3

Add abstracts to 4 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 112 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Tri-snRNP activity modulates tauopathy phenotypes (10.1093/narmme/ugaf032)
ORCID License
34.95 4
2 Triplex H-DNA Structure: The Long and Winding Road from the… (10.1093/narmme/ugae024)
References
29.40 14
3 Pi–pi stacking interactions with viral DNA contribute to the… (10.1093/narmme/ugaf039)
License
11.93 2
4 Sex-specific skeletal muscle gene expression responses to ex… (10.1093/narmme/ugaf010)
ORCID
7.53 1
5 Zika and dengue viruses differentially modulate host mRNA pr… (10.1093/narmme/ugaf015)
License
7.53 1
6 Investigation of the PIWI-interacting RNA expression differe… (10.1093/narmme/ugaf033)
ORCID
7.53 1
7 Predicting host-based, synthetic lethal antiviral targets fr… (10.1093/narmme/ugad001)
0.00 4
8 Introducing <i>NAR Molecular Medicine</i>, a new journal in… (10.1093/narmme/ugad002)
Abstract References
0.00 0
9 Coordinated evolution of the SNORD115 and SNORD116 tandem re… (10.1093/narmme/ugad003)
0.00 2
10 A small molecule that inhibits the evolution of antibiotic r… (10.1093/narmme/ugae001)
0.00 10
11 A compact regulatory RNA element in mouse Hsp70 mRNA (10.1093/narmme/ugae002)
0.00 5
12 Geno2pheno: recombination detection for HIV-1 and HEV subtyp… (10.1093/narmme/ugae003)
0.00 9
13 Self-amplifying RNAs generated with the modified nucleotides… (10.1093/narmme/ugae004)
0.00 23
14 Combating multidrug-resistance in <i>S. pneumoniae</i>: a G-… (10.1093/narmme/ugae005)
0.00 30
15 Frequencies and spectra of aflatoxin B1-induced mutations in… (10.1093/narmme/ugae006)
0.00 8
16 ATM-mediated co-chaperone DNAJB11 phosphorylation facilitate… (10.1093/narmme/ugae007)
0.00 9
17 Unlocking precision gene therapy: harnessing AAV tropism wit… (10.1093/narmme/ugae008)
0.00 12
18 Trends in drug development for rare and intractable diseases… (10.1093/narmme/ugae009)
0.00 0
19 The role of RAD51 regulators and variants in primary ovarian… (10.1093/narmme/ugae010)
0.00 3
20 Nuclear expansion and chromatin structure remodeling in mous… (10.1093/narmme/ugae011)
0.00 9
21 MONFIT: multi-omics factorization-based integration of time-… (10.1093/narmme/ugae012)
0.00 6
22 Cas9 nickase-mediated contractions of CAG/CTG repeats are tr… (10.1093/narmme/ugae013)
0.00 5
23 A novel circRNA–miRNA–mRNA regulatory axis as a sex-specific… (10.1093/narmme/ugae014)
0.00 3
24 C G composition in transposon-derived genes is increased in… (10.1093/narmme/ugae015)
0.00 1
25 Network-based modelling reveals cell-type enriched patterns… (10.1093/narmme/ugae016)
0.00 10
26 Systematic deletion of symmetrical <i>CFTR</i> exons reveals… (10.1093/narmme/ugae017)
0.00 2
27 Nuclear transfer leads to aberrant cell cycle regulation and… (10.1093/narmme/ugae018)
0.00 4
28 <i>C9orf72</i> repeat expansion creates the unstable folate-… (10.1093/narmme/ugae019)
0.00 15
29 Intercellular mosaic methylation in fast-growing <i>Mycobact… (10.1093/narmme/ugae020)
0.00 0
30 Conformation-specific RNA aptamers for phenotypic distinctio… (10.1093/narmme/ugae021)
0.00 1
31 High-affinity A/T-rich DNA binding with a dimeric bisbenzami… (10.1093/narmme/ugae022)
References
0.00 0
32 FTLD-MAPT mutations and short 5′UTR Tau mRNAs increase Tau t… (10.1093/narmme/ugae023)
0.00 5
33 A chimeric RNA consisting of siRNA and aptamer for inhibitin… (10.1093/narmme/ugae025)
0.00 2
34 Correction to ‘Nuclear transfer leads to aberrant cell cycle… (10.1093/narmme/ugae026)
Abstract References ORCID
0.00 0
35 Indole-containing inhibitors with improved efficacy targetin… (10.1093/narmme/ugae027)
0.00 2
36 Pathological PNPase variants with altered RNA binding and de… (10.1093/narmme/ugae028)
0.00 1
37 Combining CRISPR activation and interference capabilities us… (10.1093/narmme/ugaf001)
0.00 1
38 Structural, biological, and biomedical implications of mRNA… (10.1093/narmme/ugaf002)
0.00 4
39 Nucleotide level mapping of uracils in murine heavy chain sw… (10.1093/narmme/ugaf003)
0.00 0
40 <i>In silico</i> and <i>in vitro</i> mutational analysis to… (10.1093/narmme/ugaf004)
0.00 0
41 Neuromuscular dysfunction in patient-derived FUSR244RR–ALS i… (10.1093/narmme/ugaf005)
0.00 1
42 Structure-based design of a sequence-specific RNA probe that… (10.1093/narmme/ugaf006)
0.00 0
43 SRSF6 and SRSF1 coordinately enhance the inclusion of human… (10.1093/narmme/ugaf007)
0.00 5
44 High-throughput transcriptome analysis reveals a development… (10.1093/narmme/ugaf008)
0.00 1
45 The translational landscape of reactive astrocytes reveals t… (10.1093/narmme/ugaf009)
0.00 0
46 A modular CRISPRa system for molecular therapy of <i>FOXG1</… (10.1093/narmme/ugaf011)
0.00 1
47 The role of RNA in the nanoscale organization of α-synuclein… (10.1093/narmme/ugaf012)
0.00 5
48 Delineation of signaling routes that underlie differences in… (10.1093/narmme/ugaf013)
0.00 2
49 Complete stranded RNA profiling during early mouse gonad dev… (10.1093/narmme/ugaf014)
0.00 0
50 IgAim: cell surface Ig-aimed immune memory erasers for the t… (10.1093/narmme/ugaf016)
0.00 0